In clinical peptide therapy, CJC-1295 without DAC is more commonly used because it better preserves the natural pulsatile GH release pattern while still offering enhanced potency over sermorelin
Behavioral analysis and biological responses were examined after 2 years
This product is not intended to cure or prevent any disease or illness
As clinicians increasingly encounter patients with IBD as well as obesity, diabetes, or metabolic liver disease, there is a clear need to synthesize what is known about safety, metabolic effects, and IBD-specific outcomes to support evidence-informed clinical decision-making, explains senior investigator and study author Jolle St-Pierre, MD, PhD, FRCPC, a clinical assistant professor in the Division of Gastroenterology and Hepatology at the University of Calgary, Canada, in an email to Gastro Today
20 May 2009